Pharmaceuticals & Healthcare
Industry Publications

Baker & McKenzie publishes a number of newsletters to update you on the latest developments in the pharmaceuticals and healthcare industry around the world. Below are links to some of these publications, organized by region: Asia Pacific, Europe & the Middle East, and North America, including Canada and the US.

Asia Pacific

• March 2007 - Topics in this edition include: the medical insurance system in rural China, compulsory licensing and the Government Pharmaceutical Organization in Thailand, pharmaceutical industry updates in the Philippines and Malaysia, price caps on generics in Jakarta and an update on Australia/New Zealand's “Trans-Tasman” Regulatory Regime.
• November 2006 - This edition includes regulations for administering the direction for the use and labelling of Pharmaceuticals in China, the Medicine Australia Code of Conduct and the Decree implementing the Pharmaceutical Law issued in Vietnam.
• July 2006 - This edition includes updates on China's recent measures for medical device registration, new therapeutic goods enforcement measures in Australia, new decrees affecting generic names in Indonesia and restrictions on representative offices' in Vietnam.
• March 2006 - Read the latest on drugstore retailing in China, Australia's ongoing Viagra battle, Malaysia's framework for its proposed medical devices act and Thailand's free trade agreement with the US.
• November 2005 - Update yourself on updated measures for China's administration of pharmaceuticals registrations, the recent administrative order relating to intellectual property rights in the Philippines, Taiwan's actions concerning the Avian Influenza, parallel imports in Thailand and Vietnam's guidelines on bidding to supply medicines.
• August 2005 - Know more about the Australia government's intervention in health pricing, China's new health food registration and advertising rules, the Philippines' amended patent codes, Thailand's continuing product liability issues and an update on Vietnam's pharmaceutical law.
• June 2005 - Baker & McKenzie wins unfair competition action in Vietnam for major international pharmaceutical company. This newsletter also includes information on China's medical insurance system, Malaysia's directive on the use of hologram security device for medicine and the Philippines' food and drug regulatory system.
• March 2005 - This issue covers China's drug pricing rules, Australia and Indonesia's patent regulations for pharmaceuticals, Malaysia's protection of New Plant Varieties Act of 2004, the latest industry developments in the Philippines and Taiwan, and Thailand's pharmaceutical advertising regulations.

Europe, Middle East & Central Asia

• May 2008 - In this edition of the newsletter we report on the implementation of the new EFPIA code in Belgium, new legislation relating to medicinal products in France, the latest developments in the Greek Glaxo II case and the European Commission's consultation on implementation of the Advanced Therapies Regulation.
• March 2008 - We outline the European Commission's plans to combat counterfeit medicines and its recent guidance on operation of the EU database on Clinical Trials. We also comment on a court ruling in Germany that allows cooperation between pharmacies and mail-order companies for the purpose of supplying medicines to consumers. Developments in the Spanish patent system and UK developments in biosimilars are also described.
• February 2008 - In the February edition of our newsletter we report on the European Commission's "sector inquiry" into the EU pharmaceutical market, guidelines for the legitimate processing of personal data in clinical trials in Italy and pharmacovigilance developments in Spain.
• January 2008 - This edition of the European pharmaceuticals newsletter discusses the inquiry into the pharmaceutical sector launched by the European Commission. Developments regarding the UK's PPRS are also examined.

North America

• November 2007 - This issue includes articles on carbon regulation, changes in cost-recovery and contribution actions under CERCLA, and an overview of the pharmaceutical and healthcare industry, among others.
• May 2007 - This edition focuses on intellectual property developments affecting the pharmaceutical and hospital industry.
• March 2007 - The focus of this month's issue is on recent M&A developments affecting the pharmaceutical and hospital industry.
• January 2007 - This issue focuses on tax developments affecting medical device and pharmaceutical companies that have manufacturing operations in Mexico. It also discusses competent authority developments for multinational companies.
• October 2006 - This newsletter includes an article on how to determine when product innovations, exclusive contracts and bundled discounts by a monopolist are illegal. It also covers other antitrust issues such as "reverse payment" legislation and the FTC's proposed "authorized generic" drug study.
• June 2006 - This issue covers the recent Anti-Counterfeiting Law in Manufactured Goods Act, proposed compulsory drug license legislation and a summary of two recent rulings relating to joint negotiations.
• December 2005 - Update yourself on the recent FTC win on divestiture in hospital retrospective merger challenge, the Medicare Part D Program for Nursing Facilities and recent dawn raids in the European Union.
• April 2005 - This newsletter focuses on key industry issues such as corporate data security breaches, patent coverage for drugs, antitrust risks for patentees, collective fee negotiations on behalf of non-integrated physician groups and revisions to the Health Insurance Portability and Accountability Act (HIPAA) of 1996.
• February/March 2005 - In this issue, find relevant information on the alleged existence of a patient referral 'kickback' scheme at Alvarado Hospital Medical Center, the federal Sentencing Guidelines scheme for healthcare offenses and the three models for marketing and selling durable medical equipment.
• January 2005 - Get the latest news on the FTC ruling against a Texas IPA, new data security regulations under the HIPAA of 1996, the OIG's drug reimbursement methodologies and the Advocate General's decision on grey trade in support of the pharmaceutical industry.

Read more North American Pharmaceutical & Healthcare publications.